Medifocus Inc. (OTC:MDFZF.PK and TSXV:MFS) is pleased to announce that it has received approval from Health Canada to amend its pivotal Phase III study design and clinical protocol to conform to the study design and clinical protocol as approved by the Food and Drug Administration (FDA) in the USA for the Company's pivotal Phase III clinical trial on treatment of breast cancer...
More...
Threaded Mode